Follow-up Study to Assess One Boost Immunization With AFFITOPEŽ PD01A With Regard to Safety and Clinical Activity (AFF008A)
http://clinicaltrials.gov/ct2/show/N...&sel_rss=mod14
This is a follow-up study to assess safety and clinical activity of continued AFFITOPEŽ PD01A vaccinations in patients with Parkinson's disease. Patients, who have already participated in AFF008 will be involved and will be receive one boost immunization with AFFITOPEŽ PD01A. One study site in Vienna (Austria) will be involved.
In addition, up to 8 patients will be offered participation within an untreated control group.